论文部分内容阅读
目的:探讨曲安奈德治疗糖尿病患者白内障术后并发症的临床效果。方法:选择我院2014年10月-2015年10月收治的84例糖尿病性白内障患者,所有患者均为行白内障手术后出现并发症患者。根据治疗方法不同将患者分为两组,对照组患者仅使用糖皮质激素眼药水治疗,观察组在对照组基础上给予球周注射曲安奈德治疗。观察两组患者眼前节反应控制情况,并就两组患者不良反应发生情况展开分析。结果:观察组患者前房纤维蛋白渗出及色素沉着等情况显著低于对照组,差异有统计学意义(p<0.05),但眼压变化、角膜内皮细胞密度比较无明显差异(p>0.05)。观察组患者不良反应发生率7.14%显著低于对照组16.67%差异有统计学意义(p<0.05)。结论:曲安奈德治疗糖尿病患者白内障术后并发症的临床效果较好,不但能够改善患者术后炎症情况,更能帮助患者改善预后,值得临床推广。
Objective: To investigate the clinical effect of triamcinolone acetonide in the treatment of complications of cataract patients with diabetes mellitus. Methods: A total of 84 patients with diabetic cataract who were admitted to our hospital from October 2014 to October 2015 were enrolled. All of the patients had complications after cataract surgery. The patients were divided into two groups according to different treatment methods. Patients in the control group were treated with glucocorticoid eye drops only. The observation group was treated with perinuclear injection of triamcinolone acetonide on the basis of the control group. The control of anterior segment of the two groups was observed, and the incidence of adverse reactions in both groups was analyzed. Results: The anterior chamber fibrin exudation and pigmentation in the observation group were significantly lower than those in the control group (p <0.05), but there were no significant differences in intraocular pressure and corneal endothelial cell density (p> 0.05 ). The incidence of adverse reactions in observation group was significantly lower than that in control group (7.14% vs 16.67%, p <0.05). Conclusion: The clinical effect of triamcinolone acetonide in the treatment of diabetic patients with cataract complications is better, not only can improve postoperative inflammation, but also help patients improve prognosis, which is worthy of clinical promotion.